For people facing aggressive bladder cancer that no longer responds to standard treatment, options have often been grim—either undergo life-changing surgery to remove the bladder or try less effective ...
Radical cystectomy, or complete bladder removal, remains the standard and most effective surgery for muscle‑invasive bladder ...
There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report. An experimental new drug with the unwieldy name of cretostimogene ...
A continent urostomy is a type of urinary diversion surgery that may be recommended in cases where your bladder isn’t functioning normally due to injury or disease. Unlike other types of urostomies, ...
NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without ...
UC San Diego Health is the first health system in San Diego County to offer a new bladder-saving gene therapy to treat localized bladder cancer. The novel treatment is the first and only FDA-approved ...
TAR-200 plus cetrelimab effective in reducing tumor size in those with muscle-invasive disease, potentially improving surgical outcomes and lowering risk of recurrence In the interim analysis of the ...
UC San Diego Health is the first health system in San Diego County to offer a new bladder-saving gene therapy to treat localized bladder cancer. The novel treatment is the first and only FDA-approved ...
Detailed price information for Theralase Techs Inc (TLTFF) from The Globe and Mail including charting and trades.